Hindustan Bio Sciences Share Price
7.45+0.10 (+1.36%)
-8.02% past 1 Year
Hindustan Bio Sciences Limited is engaged in the manufacturing and sale of pharmaceutical products. The company was incorporated under the Companies Act, 1956 as a public limited on December 16,
Corporate filings & documents
Announcements
With Reference to the subject cited please find the 34th Annual Report along with the intimation for the financial year 2025-26
22 hours agoWith Reference to the subject cited please find the 34th Annual Report along with the intimation for the financial year 2025-26
22 hours agoSubmission of 34th Annual Report including the notice of Annual General Meeting for the financial year 2025-26 under regulation 34 of SEBI (LODR) Regulation 2015
23 hours agoSubmission of 34th Annual Report including the notice of Annual General Meeting for the financial year 2025-26 under regulation 34 of SEBI (LODR) Regulation 2015
23 hours agoOutcome of the Board Meeting held on 31-08-2026
4 days agoOutcome of the Board Meeting held on 31-08-2026
4 days agoHindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2026 inter alia to consider and approve Draft scheme of Reorganization/Rearrangement of Share Capital of the company
1 week agoHindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/08/2026 inter alia to consider and approve Draft scheme of Reorganization/Rearrangement of Share Capital of the company
1 week agoNewspaper Publication of un-audited financial results for the quarter ended 30th June 2026
1 month agoNewspaper Publication of un-audited financial results for the quarter ended 30th June 2026
1 month agoApproval of Un-audited Financial Results of the company for the first quarter ended 30 june 2026 along with Limited Review Report issued by statutory auditor
1 month agoApproval of Un-audited Financial Results of the company for the first quarter ended 30 june 2026 along with Limited Review Report issued by statutory auditor
1 month agoOutcome of the Board Meeting held on Friday July 31 2026 as Required under Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015
1 month agoOutcome of the Board Meeting held on Friday July 31 2026 as Required under Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation 2015
1 month agoHindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve With reference to the subject cited this is to inform the Exchange that meeting of the Board of Directors of M/s. Hindustan Bio Sciences Limited will be held on Friday the 31st day of July 2026. at the registered office of the company situated at Plot No: 31 Sagar Co-Operative Housing Society Road No: 2 Banjara Hills Hyderabad - 500 034 to consider the following:1. Un-audited financial results of the company for the quarter ended 30.06.20262. Any other matter with the permission of Chair.
1 month agoHindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve With reference to the subject cited this is to inform the Exchange that meeting of the Board of Directors of M/s. Hindustan Bio Sciences Limited will be held on Friday the 31st day of July 2026. at the registered office of the company situated at Plot No: 31 Sagar Co-Operative Housing Society Road No: 2 Banjara Hills Hyderabad - 500 034 to consider the following:1. Un-audited financial results of the company for the quarter ended 30.06.20262. Any other matter with the permission of Chair.
1 month agoWe are hereby submitting the Compliance Certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with 74(5) of SEBI(D&P) Regulations 2018 for the first quarter ended 30th June 2026
1 month agoWe are hereby submitting the Compliance Certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with 74(5) of SEBI(D&P) Regulations 2018 for the first quarter ended 30th June 2026
1 month agoThe trading window for dealing in the securities of the company will remain closed from 01st July 2026 till 48 hours after announcement of Standalone Un-Audited Financial results for the quarter ending on June 30 2026
2 months agoThe trading window for dealing in the securities of the company will remain closed from 01st July 2026 till 48 hours after announcement of Standalone Un-Audited Financial results for the quarter ending on June 30 2026
2 months agoNewspaper publication as per regulation 47 of SEBI (LODR) 2015.
3 months agoAppointment of Internal Auditor for the year 2026-27
3 months agoAppointment of Internal Auditor for the year 2026-27
3 months agoAudited Financial Results for the Fourth Quarter and Financial year ended 31st March 2026
3 months agoAudited Financial Results for the Fourth Quarter and Financial year ended 31st March 2026
3 months agoFinancial Results for the Fourth Quarter and Financial Year ended 31st March 2026
3 months agoFinancial Results for the Fourth Quarter and Financial Year ended 31st March 2026
3 months agoAnnual Secretarial Compliance Report for the year ended 31 March 2026
3 months agoAnnual Secretarial Compliance Report for the year ended 31 March 2026
3 months agoHindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Hindustan Bio Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Intimation of Board Meeting under regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure requirements) regulations 2015
3 months agoHindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Hindustan Bio Sciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Intimation of Board Meeting under regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure requirements) regulations 2015
3 months agoWe are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with the Regulation 74(5) of SEBI(Depositories and Participants) Regulation 2018 for the Fourth quarter and year ended on 31st March 2026
4 months agoWe are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with the Regulation 74(5) of SEBI(Depositories and Participants) Regulation 2018 for the Fourth quarter and year ended on 31st March 2026
4 months agoThe Trading window for the dealing in securities of the Company will remain closed from April 01 2026 till 48 hours after the announcement of Standalone Audited Financial results for the year ending on March 31 2026
5 months agoThe Trading window for the dealing in securities of the Company will remain closed from April 01 2026 till 48 hours after the announcement of Standalone Audited Financial results for the year ending on March 31 2026
5 months agoWe are hereby submitting the Newspaper Advertisement in Hitech Edition (English Language) and Prajapalana (Telugu Language) regarding Unaudited Standalone financial results for the Third Quarter ended on December 31 2025
7 months agoUn-audited results for quarter ended 31-12-2025
7 months agoOutcome of Board Meeting
7 months agoThe Exchange has received the revised disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bosco Armando Menezes & Emily Bosco Menezes
7 months agoIntimation under SAST regulation 29(2)
7 months agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Bosco Armando Menezes & Emily Bosco Menezes
7 months agoHindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2026 inter alia to consider and approve Intimation of Board Meeting under regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure requirements) regulations 2015
7 months agoSpecial window for re-lodgment of transfer requests of physical shares pursuant to SEBI circular dated July 2 2025
7 months agoCertificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the period ended 31st December 2025
7 months agoClosure of Trading Window
8 months agoSpecial Window for re-lodgment of transfer requests of physical shares pursuant to SEBI circular dated July 2 2025
8 months agoNewspaper Publication of Un-audited financial results for the half year and quarter ended 30th September 2025
10 months agoOutcome of board meeting held on 31-10-2025
10 months agoHindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 inter alia to consider and approve Unaudited Standalone Financial Results for the Second quarter and half year ended on September 30 2025 along with Limited Review Report
10 months agoSpecial window for re-lodgment of transfer request of physical shares pursuant to SEBI circular dated July 2 2025
10 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
H No.8-2-269/ S, Plot No 31 Sagar Co-operative Housing Society Road No 2, Banjara Hills Hyderabad Telangana PIN: 500034 Tel No: 040- 23555161 / 23555181 Fax No: 040- 23549411 Email: [email protected] Internet: www.hindustanbiosciences.in
Registrars
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57, 4th & 5th Floors, Jayabheri Enclave Phase - II, Gachibowli(Old Address:12-10-167, MIG- 167,Bharat Nagar Colony, Hyderabad – 500018.)Phone: +91-40-23818475/6Fax : +91-40-23868024Email: info@vccili Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57 4th & 5th Floors Jayabheri Enclave Phase - II, Gachibowli PIN: Tel No: 23818475,23868257,35164910 Fax No: NULL Email: [email protected] Internet: www.vccipl.com
Management
J V R Mohan Raju, Chairman & Managing Director
J V R Mohan Raju, Chairman & Managing Director
Reji Abraham, Non Executive Independent Director
J Uma, Promoter & Non-Executive Director
Jaison George, Non Independent & Non Executive Director
Bodeddula Nagi Reddy, Non Executive Independent Director
Gorrela Pratheek Reddy, Non Executive Independent Director
Shailendra Vyas, Company Secretary & Compliance Officer
Details
BSE 532041
NSE NULL
ISIN INE597C01021